Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Recruiting 2Terminated 1Approved for marketing 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Skin Neoplasms 6Neoplasms 6Melanoma 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Squamous Cell 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Merkel Cell 2Advanced Non-Small Cell Lung Cancer 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Liposarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1

Interventions

Nivolumab 3Specimen Handling 2Radiotherapy 2Ipilimumab 2CTLA-4 Antigen 2tocilizumab 1talimogene laherparepvec 1sonidegib 1prednylidene 1poly ICLC 1pembrolizumab 1flt3 ligand protein 1deltacortene 1cemiplimab 1Tomography, Optical Coherence 1Tacrolimus 1Radiation 1Prednisone 1Papillomavirus Vaccines 1Mohs Surgery 1Microscopy, Confocal 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Blood Specimen Collection 1Biopsy 1BO-112 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Basal Cell × cemiplimab × Clear all
NCT04679480 2024-07-30

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

University of Zurich

Phase 2 Active not recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡